ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.884,75
-0,57%
S&P 500
5.930,85
1,09%
Dow Jones
42.840,26
1,18%
Euro vs US Dollar
1,043
0,00%
Bitcoin
96.296,15
-0,93%
Pepperstone
Advertisement
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. TELA Bio Inc (TELA) Börsenkurse

TELA Bio Inc

TELA Bio Inc (TELA)

NASDAQ
2,85
0,05
(1,79%)
Geschlossen 22 Dezember 10:00PM
Verzögert um 15 Minuten
2,85
-0,04
(-1,38%)
Nach Börsenschluss: 12:55AM
Verzögert um 15 Minuten

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Wichtige Statistiken und Details

Current Price
2,85
Gebot
2,60
Fragen
3,47
Volumen
1.622.762
2,71 Tagesbereich 2,96
2,30 52-Wochen-Bereich 7,84
Marktkapitalisierung
112,257M
Handelsende
2,80
Handelsbeginn
2,93
Letzte Trade
1
@
2.7
Letzter Handelszeitpunkt
Finanzvolumen
US$ 4.704.846
VWAP
2,8993
Durchschnittliches Volumen (3 Mio.)
220.125
Ausgegebene Aktien
39.388.443
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-2,44
Gewinn pro Aktie (EPS)
-1,18
Erlöse
58,45M
Nettogewinn
-46,66M

Über TELA Bio Inc

TELA Bio Inc is a United States-based medical technology company. The company is involved in developing and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. Its reinforced tissue matrices called OviTex improve the clinical outcomes and reduce costs of... TELA Bio Inc is a United States-based medical technology company. The company is involved in developing and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. Its reinforced tissue matrices called OviTex improve the clinical outcomes and reduce costs of care in hernia repair, abdominal wall reconstruction and plastic and reconstructive surgery. Mehr anzeigen

Sektor
Surgical,med Instr,apparatus
Branche
Surgical,med Instr,apparatus
Website
www.telabio.com
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
TELA Bio Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker TELA. The last closing price for TELA Bio was US$2,80. Over the last year, TELA Bio shares have traded in a share price range of US$ 2,30 to US$ 7,84.

TELA Bio currently has 39.388.443 shares in issue. The market capitalisation of TELA Bio is US$110,29 million. TELA Bio has a price to earnings ratio (PE ratio) of -2.44.

TELA Neueste Nachrichten

Weitere Nachrichten

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., Dec. 13, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue...

13 Dezember 2024
GlobeNewswire Inc.

TELA Bio to Participate in Piper Sandler’s 36th Annual Healthcare Conference

MALVERN, Pa., Nov. 19, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions...

19 November 2024
GlobeNewswire Inc.

Form 8-K - Current report

07 November 2024
Edgar (US Regulatory)

TELA Bio Reports Third Quarter 2024 Financial Results

MALVERN, Pa., Nov. 07, 2024 (GLOBE NEWSWIRE) --  TELA Bio, Inc. ("TELA Bio"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions...

07 November 2024
GlobeNewswire Inc.

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., Nov. 01, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue...

01 November 2024
GlobeNewswire Inc.

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

28 Oktober 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

24 Oktober 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

24 Oktober 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

24 Oktober 2024
Edgar (US Regulatory)

TELA Bio Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

MALVERN, Pa., Oct. 24, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction, today announced...

24 Oktober 2024
GlobeNewswire Inc.
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.031.063829787232.823.042.681333132.81301313CS
4-0.05-1.724137931032.93.22.681415832.9060534CS
120.217.954545454552.643.262.32201252.82044607CS
26-2.25-44.11764705885.15.562.32176073.28466353CS
52-2.71-48.74100719425.567.842.31782964.23570364CS
156-9.69-77.272727272712.5413.72.31101296.17501828CS
260-10.2-78.160919540213.0523.5452.3829107.74490822CS

TELA - Frequently Asked Questions (FAQ)

What is the current TELA Bio share price?
The current share price of TELA Bio is US$ 2,85
How many TELA Bio shares are in issue?
TELA Bio has 39.388.443 shares in issue
What is the market cap of TELA Bio?
The market capitalisation of TELA Bio is USD 110,29M
What is the 1 year trading range for TELA Bio share price?
TELA Bio has traded in the range of US$ 2,30 to US$ 7,84 during the past year
What is the PE ratio of TELA Bio?
The price to earnings ratio of TELA Bio is -2,44
What is the cash to sales ratio of TELA Bio?
The cash to sales ratio of TELA Bio is 1,95
What is the reporting currency for TELA Bio?
TELA Bio reports financial results in USD
What is the latest annual turnover for TELA Bio?
The latest annual turnover of TELA Bio is USD 58,45M
What is the latest annual profit for TELA Bio?
The latest annual profit of TELA Bio is USD -46,66M
What is the registered address of TELA Bio?
The registered address for TELA Bio is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the TELA Bio website address?
The website address for TELA Bio is www.telabio.com
Which industry sector does TELA Bio operate in?
TELA Bio operates in the SURGICAL,MED INSTR,APPARATUS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
MYSZMy Size Inc
US$ 4,2001
(211,12%)
121,03M
NVNINVNI Group Ltd
US$ 8,26
(209,36%)
78,06M
TPICTPI Composites Inc
US$ 2,45
(100,82%)
34M
ICGIntchains Group Ltd
US$ 8,77
(88,60%)
527,94k
HSDTHelius Medical Technologies Inc
US$ 0,884851
(84,34%)
121,95M
CYNCYNGN Inc
US$ 0,4603
(-71,41%)
27,91M
MTEMMolecular Templates Inc
US$ 0,1502
(-57,09%)
8,75M
PRFXPainReform Ltd
US$ 5,15
(-53,85%)
2,94M
GALTGalectin Therapeutics Inc
US$ 1,03
(-48,50%)
9,27M
BCABBioAtla Inc
US$ 0,6923
(-41,82%)
6,25M
EDBLEdible Garden AG Inc
US$ 0,24
(65,06%)
354,33M
NVDANVIDIA Corporation
US$ 134,70
(3,08%)
310,19M
APTOAptose Biosciences Inc
US$ 0,28
(64,51%)
306,25M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,606999
(6,49%)
293,22M
PLTRPalantir Technologies Inc
US$ 80,55
(8,54%)
281,23M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
TELA
TELA Bio
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten